Results 41 to 50 of about 549,379 (280)

Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer

British Journal of Cancer, 2020
When treating patients with unresectable stage III non-small-cell lung cancer (NSCLC), those with a good performance status and disease measured within a radical treatment volume should be considered for definitive concurrent chemoradiotherapy (cCRT ...
J. Conibear
semanticscholar   +1 more source

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer [PDF]

Radiation Oncology Journal, 2014
Survival outcome of locally advanced pancreatic cancer has been poor and little is known about prognostic factors of the disease, especially in locally advanced cases treated with concurrent chemoradiation. This study was to analyze overall survival and prognostic factors of patients treated with concurrent chemoradiotherapy (CCRT) in locally advanced ...
Tae-Ho Hong, Yoo-Kang Kwak, Hoo-Geun Chun, Hong Seok Jang, Dong Goo Kim, Myung-Ah Lee, Young Kyoung You, Jong-Hoon Lee   +7 more
openaire   +3 more sources

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma

Case Reports in Oncology, 2014
Little information is available about the usefulness of concurrent chemoradiotherapy for locally advanced thymic carcinoma due to a rare anterior mediastinal tumor.
Toshirou Fukushima, Kazunari Tateishi, Masayuki Hanaoka, Keiichirou Koiwai, Shigeru Sasaki, Tomonobu Koizumi   +5 more
doaj   +1 more source

Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer in comparison with chemoradiotherapy alone

Thoracic Cancer, 2020
Durvalumab after concurrent chemoradiotherapy (CCRT) for locally advanced non‐small cell lung cancer (LA‐NSCLC) has been found to significantly improve overall survival (OS). However, the effect of durvalumab on local control remains unclear.
T. Abe, S. Saito, Misaki Iino, Tomomi Aoshika, Yasuhiro Ryuno, T. Ohta, Mitsunobu Igari, Ryuta Hirai, Y. Kumazaki, Y. Miura, K. Kaira, H. Kagamu, S. Noda, S. Kato   +13 more
semanticscholar   +1 more source

Therapeutic efficacy of rare earth carbonate with chemoradiotherapy in late-stage non-small cell lung cancer: a cohort prospective study

Frontiers in Endocrinology, 2023
ObjectiveTo compare the therapeutic effects and adverse reactions of sterilizing rare earth carbonate combined with concurrent chemoradiotherapy and simple concurrent chemoradiotherapy in the treatment of late-stage non-small cell lung cancer (NSCLC ...
Qiang Cao, Qiang Cao, Xia Ye, Xinyan Wu, Qi Zhang, Junling Gong, Yuquan Chen, Yanwei You, Jun Shen, Yi Qiang, Guangzhu Cao   +10 more
doaj   +1 more source

Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer [PDF]

The Journal of the Korean Society for Therapeutic Radiology and Oncology, 2011
†Purpose: This study was designed to evaluate the results of local control, survival rate, prognostic factors, and failure pattern in locally advanced esophageal cancer. Materials and Methods: We retrospectively studied 50 patients with locally advanced esophageal cancer treated with concurrent chemoradiotherapy at Keimyung University Dongsan Medical ...
Ok Bae Kim, Hong Suk Song, Jinhee Kim, Sang Jun Byun   +3 more
openaire   +2 more sources

Concurrent Chemoradiotherapy with Original Chemotherapy Regimens may not be Suitable for Patients Who Failed to Respond to Induction Chemotherapy
in Limited-stage Small Cell Lung Cancer

Chinese Journal of Lung Cancer, 2016
Background and objective The group of small cell lung cancer (SCLC) are usually highly sensitive to chemotherapy, and less than 15% of them are resistant to drugs.
Daquan WANG, Liming XU, Lujun ZHAO, Wencheng ZHANG, Qingsong PANG, Ningbo LIU, Xi CHEN, Xiuli CHEN, Zhiyong YUAN, Ping WANG   +9 more
doaj   +1 more source

Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial

International Journal of Cancer, 2019
To report long‐term results of a randomized controlled trial that compared cisplatin/fluorouracil/docetaxel (TPF) induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT) with CCRT alone in locoregionally advanced nasopharyngeal carcinoma ...
Wen-Fei Li, N. Chen, Ning Zhang, G. Hu, F. Xie, Yan Sun, Xiaozhong Chen, Jin-Gao Li, Xiao-dong Zhu, Chaosu Hu, Xiangying Xu, Yuanyuan Chen, Wei‐han Hu, Ling Guo, H. Mo, Lei Chen, Y. Mao, R. Sun, P. Ai, S. Liang, Guo-Xian Long, B. Zheng, Xinglai Feng, X. Gong, Ling Li, Chunying Shen, Jian-yu Xu, Ying Guo, Yu-Ming Chen, Fan Zhang, Li Lin, L. Tang, Mengzhong Liu, Jun Ma, Ying Sun   +34 more
semanticscholar   +1 more source

Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma

Tumor Biology, 2017
Radioresistance often leads to poor survival in concurrent chemoradiotherapy–treated cervical squamous cell carcinoma, and reliable biomarkers can improve prognosis.
Oyeon Cho, Mison Chun, Young-Taek Oh, O Kyu Noh, Suk-Joon Chang, Hee-Sug Ryu, Eun Ju Lee   +6 more
doaj   +1 more source

Spontaneous ureteral rupture during concurrent chemoradiotherapy in a woman with uterine cervical cancer

Gynecologic Oncology Reports, 2015
Spontaneous rupture of the renal pelvis and ureter is associated with obstruction of the urinary collecting system, but is rarely caused by tumors. We describe our experience with a patient who had uterine cervical cancer with mild hydroureter in whom ...
Shun-ichi Ikeda, Mitsuya Ishikawa, Tomoyasu Kato   +2 more
doaj   +1 more source